Nucleoside

Results: 353



#Item
2311  . Baraclude(ß I Rx only I

1 . Baraclude(ß I Rx only I

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:47:02
232Microsoft Word - ADAPFormularyProvider81814

Microsoft Word - ADAPFormularyProvider81814

Add to Reading List

Source URL: www.azdhs.gov

Language: English - Date: 2014-08-18 15:47:48
233HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. VIRAMUNE® (nevirapine) tablets, for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. VIRAMUNE® (nevirapine) tablets, for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-01-28 14:06:56
234EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2012-12-08 13:59:40
235HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS.  ------------------------WARNINGS

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ------------------------WARNINGS

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-10 13:31:43
236EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

EDITORIAL Phased implementation of screening for cryptococcal disease in South Africa Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of

Add to Reading List

Source URL: preventcrypto.org

Language: English - Date: 2012-12-19 14:23:17
237CDER Priority Drug and Biologic Approvals in Calendar Year 2008 Updated through November 30, 2008 Priority New Drug Application (NDA) Approvals: NDA Number N022187

CDER Priority Drug and Biologic Approvals in Calendar Year 2008 Updated through November 30, 2008 Priority New Drug Application (NDA) Approvals: NDA Number N022187

Add to Reading List

Source URL: www.fda.gov

Language: English
238Information for Inuit Community Members Fact Sheet 3 HIV/AIDS -Treatment NEVIRAPINE What is Nevirapine? Nevirapine is one medicine that is part of a large family of drugs usually called Non-nucleosides

Information for Inuit Community Members Fact Sheet 3 HIV/AIDS -Treatment NEVIRAPINE What is Nevirapine? Nevirapine is one medicine that is part of a large family of drugs usually called Non-nucleosides

Add to Reading List

Source URL: pauktuutit.ca

Language: English - Date: 2012-10-31 14:14:57
239Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur

Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur

Add to Reading List

Source URL: www.janssenrnd.com

Language: English - Date: 2012-07-18 12:14:17
240Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children—A Working Group of the Office of AIDS Rese

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children—A Working Group of the Office of AIDS Rese

Add to Reading List

Source URL: aidsinfo.nih.gov

Language: English - Date: 2014-03-28 13:39:39